Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam Adjunctive Therapy in Generalized Epilepsy (China)
ChiCTR2500113984Phase 4Not yet recruiting
- Sponsor
- Huashan Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of brivaracetam in generalized epilepsy, sponsored by Huashan Hospital. Primary endpoints: Overall Response Rate (ORR), Response Rate for Generalized Seizures and 1 more. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
brivaracetam
03
Conditions
generalized epilepsy
Beyond the preview
Go deeper on ChiCTR2500113984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500113984.